Elsevier

Journal of Infection

Volume 85, Issue 2, August 2022, Pages 174-211
Journal of Infection

Letter to the Editor
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis

https://doi.org/10.1016/j.jinf.2022.04.045Get rights and content

Highlights

  • Severe and critical COVID-19 patients experience high frequency of bacteremia.

  • Bacteremia might be more frequent in remdesivir treated patients.

  • Gram positive bacteria, especially Enterococcus faecalis are of special concern.

  • Occurrence of bacteremia moderates association of remdesivir use with survival.

Keywords

SARS-CoV-2
Blood cultures
Immunosuppression
Bacteremia

Cited by (0)

View Abstract